Skip to main content
Premium Trial:

Request an Annual Quote

New Products: May 17, 2011 (rev. 1)


NewGene has launched a test for hereditary breast cancer. The test identifies all mutations in the coding regions of BRCA1 and BRCA2, which are associated with inherited breast cancer. The test combines sequencing on the Roche 454 GS FLX and genotyping on Sequenom's MassArray system. According to the company, it also plans to offer tumor marker tests for metastatic colon and lung cancers, and hemato-oncology tests.

The Scan

Push Toward Approval

The Wall Street Journal reports the US Food and Drug Administration is under pressure to grant full approval to SARS-CoV-2 vaccines.

Deer Exposure

About 40 percent of deer in a handful of US states carry antibodies to SARS-CoV-2, according to Nature News.

Millions But Not Enough

NPR reports the US is set to send 110 million SARS-CoV-2 vaccine doses abroad, but that billions are needed.

PNAS Papers on CRISPR-Edited Cancer Models, Multiple Sclerosis Neuroinflammation, Parasitic Wasps

In PNAS this week: gene-editing approach for developing cancer models, role of extracellular proteins in multiple sclerosis, and more.